Chapter 1. Introduction
1.1. Report Description And Scope
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
Chapter 2. Executive Summary
2.1. Global Endocrine Testing Market, 2015 - 2021 (USD Million)
2.2. Global Endocrine Testing Market: Snapshot
Chapter 3. Endocrine Testing Market Dynamics
3.1. Introduction
3.2. Market Drivers
3.2.1. Global Endocrine testing Market Drivers: Impact Analysis
3.2.2. Rising Diabetic and Obese Population
3.3. Market Restraints
3.3.1. Global Endocrine testing Market Restraints: Impact Analysis
3.3.2. High Cost of Technology
3.4. Opportunities
3.4.1. Innovative Products
3.5. Porters Five Forces Analysis
3.5.1. Bargaining Power Of Suppliers
3.5.2. Bargaining Power Of Buyers
3.5.3. Threat From New Entrants
3.5.4. Threat From New Substitutes
3.5.5. Degree Of Competition
3.6. Market Attractiveness Analysis
3.6.1. Market Attractiveness Analysis, By Test Segment
3.6.2. Market Attractiveness Analysis, By Technology Segment
3.6.3. Market Attractiveness Analysis, By End-User Segment
3.6.4. Market Attractiveness Analysis, By Regional Segment
Chapter 4. Global Endocrine Testing Market Competitive Landscape
4.1. Company Market Share, 2015 (Subject To Data Availability)
4.2. Strategic Development
4.2.1. Acquisitions Mergers
4.2.2. New Type Launch
4.2.3. Agreements, Partnerships, Collaborations And Joint Ventures
4.2.4. Research And Development, Regional Expansion
4.3. Type Portfolio
Chapter 5. Global Endocrine Testing Market Test Analysis
5.1. Global Endocrine Testing Market: Test Segment Overview
5.1.1. Global Endocrine Testing Market Revenue Share, By Test, 2015 And 2021
5.2. Dehydroepiandrosterone Sulfate
5.2.1. Global Endocrine Testing Market for Dehydroepiandrosterone Sulfate, 2015 2021 (USD Million)
5.3. Progesterone
5.3.1. Global Endocrine Testing Market for Progesterone, 2015 2021 (USD Million)
5.4. Luteinizing Hormone
5.4.1. Global Endocrine Testing Market For Luteinizing Hormone, 2015 2021 (USD Million)
5.5. Estradiol
5.5.1. Global Endocrine Testing Market for Estradiol, 2015 2021 (USD Million)
5.6. Human Chorionic Gonadotropin
5.6.1. Global Endocrine Testing Market for Human Chorionic Gonadotropin, 2015 2021 (USD Million)
5.7. Follicle Stimulating
5.7.1. Global Endocrine Testing Market for Follicle Stimulating, 2015 2021 (USD Million)
5.8. Testosterone
5.8.1. Global Endocrine Testing Market for Testosterone, 2015 2021 (USD Million)
5.9. Thyroid Prolactin
5.9.1. Global Endocrine Testing Market for Thyroid Prolactin, 2015 2021 (USD Million)
5.10. Thyroid Stimulating Hormone
5.10.1. Global Endocrine Testing Market for Thyroid Stimulating Hormone, 2015 2021 (USD Million)
5.11. Cortisol
5.11.1. Global Endocrine Testing Market for Cortisol, 2015 2021 (USD Million)
5.12. Insulin
5.12.1. Global Endocrine Testing Market for Insulin, 2015 2021 (USD Million)
5.13. Others
5.13.1. Global Endocrine Testing Market for Other Test, 2015 2021 (USD Million)
Chapter 6. Global Endocrine Testing Market Technology Segment Analysis
6.1. Global Endocrine testing Market: Technology Segment Overview
6.1.1. Global Endocrine testing Market Revenue Share, By Technology, 2015 And 2021
6.2. Monoclonal Polyclonal Antibody Technologies
6.2.1. Global Endocrine Testing Market For Monoclonal Polyclonal Antibody Technologies, 2015 2021 (USD Million)
6.3. Tandem Mass Spectrometry
6.3.1. Global Endocrine Testing Market For Tandem Mass Spectrometry, 2015 2021 (USD Million)
6.4. Immunoassay
6.4.1. Global Endocrine Testing Market for Immunoassay, 2015 2021 (USD Million)
6.5. Clinical Chemistry Technologies
6.5.1. Global Endocrine Testing Market for Clinical Chemistry Technologies, 2015 2021 (USD Million)
6.6. Other
6.6.1. Global Endocrine Testing Market for Other Technologies, 2015 2021 (USD Million)
Chapter 7. Global Endocrine Testing Market End-User Segment Analysis
7.1. Global Endocrine testing Market: End-User Segment Overview
7.1.1. Global Endocrine testing Market Revenue Share, By End-User, 2015 And 2021
7.2. Commercial Laboratories
7.2.1. Global Endocrine Testing Market For Commercial Laboratories, 2015 2021 (USD Million)
7.3. Home-Based Tests
7.3.1. Global Endocrine Testing Market for Home-Based Tests 2015 2021 (USD Million)
7.4. Ambulatory Care Centers
7.4.1. Global Endocrine Testing Market for Ambulatory Care Centers 2015 2021 (USD Million)
7.5. Hospitals
7.5.1. Global Endocrine Testing Market for Hospitals 2015 2021 (USD Million)
7.6. Other
7.6.1. Global Endocrine Testing Market for other, 2015 2021 (USD Million)
Chapter 8. Global Endocrine Testing Market Regional Segment Analysis
8.1. Global Endocrine Testing Market: Regional Overview
8.1.1. Global Endocrine Testing Market Revenue Share, By Region, 2015 And 2021
8.2. North America
8.2.1. North America Endocrine Testing Market Revenue, By Test, 2015 2021 , (Usd Million)
8.2.2. North America Endocrine Testing Market Revenue, By Technology, 2015 2021 , (USD Million)
8.2.3. North America Endocrine Testing Market Revenue, By End-User Type, 2015 2021 , (USD Million)
8.3. Europe
8.3.1. Europe Endocrine Testing Market Revenue, By Test, 2015 2021 (USD Million)
8.3.2. Europe Endocrine Testing Market Revenue, By Technology, 2015 2021 (USD Million)
8.3.3. Europe Endocrine Testing Market Revenue, By End-User Type, 2015 2021 (USD Million)
8.4. Asia Pacific
8.4.1. Asia Pacific Endocrine Testing Market Revenue, By Test, 2015 2021 (USD Million)
8.4.2. Asia Pacific Endocrine Testing Market Revenue, By Technology, 2015 2021 (USD Million)
8.4.3. Asia Pacific Endocrine Testing Market Revenue, By End-User Type, 2015 2021 (USD Million)
8.5. Latin America
8.5.1. Latin America Endocrine Testing Market Revenue, By Test, 2015 2021 (USD Million)
8.5.2. Latin America Endocrine Testing Market Revenue, By Technology, 2015 2021 (USD Million)
8.5.3. Latin America Endocrine Testing Market Revenue, By End-User Type, 2015 2021 (USD Million)
8.6. Middle East And Africa
8.6.1. Middle East And Africa Endocrine Testing Market Revenue, By Test, 2015 2021 (USD Million)
8.6.2. Middle East And Africa Endocrine Testing Market Revenue, By Technology, 2015 2021 (USD Million)
8.6.3. Middle East And Africa Endocrine Testing Market Revenue, By End-User Type, 2015 2021 (USD Million)
Chapter 9. Company Profile
9.1. Abbott Laboratories
9.1.1. Overview
9.1.2. Financials
9.1.3. Product Portfolio
9.1.4. Business Strategy
9.1.5. Recent Developments
9.2. AB Sciex Pte.Ltd.
9.2.1. Overview
9.2.2. Financials
9.2.3. Product Portfolio
9.2.4. Business Strategy
9.2.5. Recent Developments
9.3. Agilent Technologies
9.3.1. Overview
9.3.2. Financials
9.3.3. Product Portfolio
9.3.4. Business Strategy
9.3.5. Recent Developments
9.4. Biomedical Technologies.
9.4.1. Overview
9.4.2. Financials
9.4.3. Product Portfolio
9.4.4. Business Strategy
9.4.5. Recent Developments
9.5. bioMerieux SA
9.5.1. Overview
9.5.2. Financials
9.5.3. Product Portfolio
9.5.4. Business Strategy
9.5.5. Recent Developments
9.6. Bio-Rad Laboratories.
9.6.1. Overview
9.6.2. Financials
9.6.3. Product Portfolio
9.6.4. Business Strategy
9.6.5. Recent Developments
9.7. DiaSorin S.p.A.
9.7.1. Overview
9.7.2. Financials
9.7.3. Product Portfolio
9.7.4. Business Strategy
9.7.5. Recent Developments
9.8. Hoffmann-La Roche Ltd.
9.8.1. Overview
9.8.2. Financials
9.8.3. Product Portfolio
9.8.4. Business Strategy
9.8.5. Recent Developments
9.9. Quest Technology
9.9.1. Overview
9.9.2. Financials
9.9.3. Product Portfolio
9.9.4. Business Strategy
9.9.5. Recent Developments
9.10. Thermo Fisher Scientific, Inc.
9.10.1. Overview
9.10.2. Financials
9.10.3. Product Portfolio
9.10.4. Business Strategy
9.10.5. Recent Developments